Allogene Therapeutics, Inc. ALLO
0.63 USD -0.04 (-5.88%)
Regular-session close
0.63 +0.01 +1.12%
After hours · Nov 20, 7:37 PM ET
0.6192 Day range 0.67
0.6277 52-week range 3.06
- YTD
- -54.18%
- 1 year
- -49.38%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -209.31M | -273.20M | -327.74M | -335.54M | -180.19M | |
| -190.89M | -257.59M | -327.26M | -340.41M | -182.05M | |
| -0.87 | -1.32 | -2.09 | -2.38 | -1.34 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 61.98M | 85.51M | 93.45M | 72.20M | 183.61M | |
| 415.90M | 548.71M | 642.84M | 821.58M | 1.05B | |
| 123.36M | 126.53M | 130.60M | 154.70M | 125.63M | |
| 292.54M | 422.18M | 512.23M | 666.88M | 925.20M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -149.25M | -200.30M | -237.73M | -220.52M | -184.81M | |
| 95.56M | 75.69M | 163.29M | 106.16M | 163.66M | |
| 30.16M | 116.67M | 95.69M | 2.95M | 11.96M | |
| -386.00K | -694.00K | -1.52M | -5.19M | -21.45M | |
| -23.53M | -7.94M | 21.25M | -111.41M | -9.19M |
